ERBB2 and chromosome 17 centromere studies of ovarian cancer by fluorescence in situ hybridization
- 1 June 1996
- journal article
- research article
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 16 (2) , 130-137
- https://doi.org/10.1002/(sici)1098-2264(199606)16:2<130::aid-gcc7>3.0.co;2-0
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Screening for early ovarian cancer.Radiology, 1994
- Screening for ovarian carcinoma: Hopeful and wishful thinkingAmerican Journal of Obstetrics and Gynecology, 1994
- Is C-ERB B-2 a predictor for recurrent disease in early stage breast cancer?International Journal of Radiation Oncology*Biology*Physics, 1994
- Analysis of cerbB2 expression using a panel of 6 commercially available antibodiesPathology, 1994
- Ovarian cancerCancer Genetics and Cytogenetics, 1992
- Expression and amplification of the HER-2/ neu (c-erbB-2) protooncogene in epithelial ovarian tumors and cell linesAmerican Journal of Obstetrics and Gynecology, 1991
- Chromosome abnormalities in human epithelial ovarian malignanciesGynecologic Oncology, 1990
- Tribute to Patrick Steptoe: beginnings of laparoscopyHuman Reproduction, 1989
- Amplification of c-erbB-2 and Aggressive Human Breast Tumors?Science, 1988
- Chromosomes 1 in 14 ovarian cancersHuman Genetics, 1977